Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Jul;30(1):41–48. doi: 10.1111/j.1365-2125.1990.tb03741.x

Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity.

G Stacher 1, H Bergmann 1, C Schneider 1, G Steiner-Mittelbach 1, G Gaupmann 1, H Steinringer 1, T A Abatzi 1, G Stacher-Janotta 1
PMCID: PMC1368273  PMID: 2390431

Abstract

1. The selective 5-HT3 receptor antagonist, ICS 205-930 (Sandoz), has been reported to have potent effects on gastric smooth muscle in vivo and to enhance gastric emptying in animals and in man. 2. This study investigated the effects of ICS 205-930 on fat-delayed gastric emptying of a semisolid meal and antral motor activity in humans. 3. Twelve healthy men participated in each of three studies in which 10 or 20 mg of ICS 205-930 or placebo were infused i.v. in a random double-blind fashion. Gastric emptying and antral motor activity were studied scintigraphically. 4. Gastric emptying was not altered after 10 mg but slower after 20 mg of ICS 205-930 than after placebo. Emptying after 20 mg of ICS 205-930 was significantly slower than after 10 mg of ICS 205-930. 5. Antral contraction amplitude was slightly lower after 20 mg of ICS 205-930 than after placebo, whereas the effects of 10 mg ICS 205-930 did not differ from those of placebo. 6. The results suggest that the investigated doses of ICS 205-930 have only slight effects on gastric motor activity of healthy young men, with 20 mg reducing the rate of emptying.

Full text

PDF
41

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akkermans L. M., Vos A., Hoekstra A., Roelofs J. M., Horowitz M. Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects. Gut. 1988 Sep;29(9):1249–1252. doi: 10.1136/gut.29.9.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson J. V., Coupe M. O., Morris J. A., Hodgson H. J., Bloom S. R. Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist. Br Med J (Clin Res Ed) 1987 May 2;294(6580):1129–1129. doi: 10.1136/bmj.294.6580.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buchheit K. H., Costall B., Engel G., Gunning S. J., Naylor R. J., Richardson B. P. 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo. J Pharm Pharmacol. 1985 Sep;37(9):664–667. doi: 10.1111/j.2042-7158.1985.tb05109.x. [DOI] [PubMed] [Google Scholar]
  4. Camilleri M., Malagelada J. R., Brown M. L., Becker G., Zinsmeister A. R. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985 Nov;249(5 Pt 1):G580–G585. doi: 10.1152/ajpgi.1985.249.5.G580. [DOI] [PubMed] [Google Scholar]
  5. Costall B., Domeney A. M., Naylor R. J., Tattersall F. D. 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology. 1986 Aug;25(8):959–961. doi: 10.1016/0028-3908(86)90030-4. [DOI] [PubMed] [Google Scholar]
  6. HUNT J. N., SPURRELL W. R. The pattern of emptying of the human stomach. J Physiol. 1951 Apr;113(2-3):157–168. doi: 10.1113/jphysiol.1951.sp004562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Leibundgut U., Lancranjan I. First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet. 1987 May 23;1(8543):1198–1198. doi: 10.1016/s0140-6736(87)92159-3. [DOI] [PubMed] [Google Scholar]
  8. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  9. Stacher G., Bergmann H., Havlik E., Schmierer G., Schneider C. Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man. Gut. 1984 May;25(5):485–490. doi: 10.1136/gut.25.5.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stacher G., Bergmann H., Wiesnagrotzki S., Kiss A., Schneider C., Mittelbach G., Gaupmann G., Höbart J. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology. 1987 Apr;92(4):1000–1006. doi: 10.1016/0016-5085(87)90976-0. [DOI] [PubMed] [Google Scholar]
  11. Stacher G., Gaupmann G., Schneider C., Stacher-Janotta G., Steiner-Mittelbach G., Abatzi T. A., Steinringer H. Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men. Br J Clin Pharmacol. 1989 Sep;28(3):315–322. doi: 10.1111/j.1365-2125.1989.tb05432.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stemper T. J. Gastric emptying and its relationship to antral contractile activity. Gastroenterology. 1975 Sep;69(3):649–653. [PubMed] [Google Scholar]
  13. Valenzuela J. E., Defilippi C. Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat. Gastroenterology. 1981 Nov;81(5):898–902. [PubMed] [Google Scholar]
  14. Weisbrodt N. W., Wiley J. N., Overholt B. F., Bass P. A relation between gastroduodenal muscle contractions and gastric empyting. Gut. 1969 Jul;10(7):543–548. doi: 10.1136/gut.10.7.543. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES